DVA (DaVita) Other Long-Term Liabilities: $99 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DVA DaVita Inc DVA
89 GF Score
Price $182.79
GF Value $194.94
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is DaVita Other Long-Term Liabilities?

DaVita DVA +1.90% 89 Other Long-Term Liabilities is $99 Mil as of Jun. 2026. GuruFocus rates DVA with a GF Score™ of 89/100 and a GF Value™ of $194.94 (Fairly Valued). The stock has 6 warning signs investors should review.

DaVita's other long-term liabilities for the quarter that ended in Jun. 2026 was $99 Mil.

DaVita's quarterly other long-term liabilities increased from Dec. 2025 ($84 Mil) to Mar. 2026 ($89 Mil) and increased from Mar. 2026 ($89 Mil) to Jun. 2026 ($99 Mil).

DaVita's annual other long-term liabilities declined from Dec. 2023 ($183 Mil) to Dec. 2024 ($170 Mil) and declined from Dec. 2024 ($170 Mil) to Dec. 2025 ($84 Mil).

DaVita Other Long-Term Liabilities Related Terms

DaVita Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for DaVita's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DaVita Other Long-Term Liabilities Chart

DaVita Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 119.16 105.23 183.07 169.59 83.52

DaVita Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 156.49 172.19 83.52 88.85 99.09
DVA
89GF Score
DaVita Inc DVA
Other Long-Term Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DaVita Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of $99 Mil mean?
DaVita (DVA) has a Other Long-Term Liabilities of $99 Mil as of Jun. 2026. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on DaVita and its competitors.
Is DaVita's Other Long-Term Liabilities too high?
DaVita's current Other Long-Term Liabilities is $99 Mil. Overall, DaVita has a GF Score™ of 89/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does DaVita's Other Long-Term Liabilities compare to EHC and UHS?
DaVita's Other Long-Term Liabilities of $99 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Healthcare Providers & Services company?
A good Other Long-Term Liabilities depends on the Healthcare Providers & Services industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on DaVita and its competitors. DaVita's current Other Long-Term Liabilities is $99 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DaVita stock overvalued right now?
Based on GuruFocus' analysis, DaVita (DVA) is currently considered Fairly Valued. The stock's GF Value™ is $194.94, compared to a current price of $182.79 — trading 6.2% below its estimated fair value. The current Other Long-Term Liabilities is $99 Mil. DaVita's overall GF Score™ is 89/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For DaVita (DVA), the current Other Long-Term Liabilities is $99 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DaVita (DVA) Overvalued in 2026?

Based on GuruFocus' analysis, DaVita stock appears to be undervalued. The current stock price of $182.79 is trading 6.2% below its estimated GF Value™ of $194.94. GuruFocus considers DaVita to be Fairly Valued.

Key valuation signals for DVA:

  • Other Long-Term Liabilities: $99 Mil
  • GF Value™: $194.94 vs. price of $182.79 (6.2% below fair value)
  • GF Score™: 89/100 with 6 warning signs

No single metric tells the full story. See the DVA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DaVita Business Description

Address 2000 16th Street, Denver, CO, USA, 80202
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
89GF Score

Get the complete analysis for DVA

Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$182.79
Price
$194.94
GF Value